Mario Nespoli is the new CFO of BIOGENERA
BIOGENERA has appointed as the company’s new chief financial officer (CFO) Dr. Mario Nespoli, who has many years of experience in the pharmaceutical industry at management levels.
INTEGRAE SIM is chosen as Listing Sponsor and Global Coordinator.
BIOGENERA has chosen INTEGRAE SIM (a leading Italian company in extraordinary finance for SMEs with more than 60 successfully completed IPOs) as Listing Sponsor and Global Coordinator for the path of preparing the IPO on Euronext Paris.
BIOGENERA closes at more than 2.8 million raised on CrowdFundMe
BIOGENERA SpA’s crowdfunding campaign conducted on the CrowdFundMe digital platform, which ended in October 2021, recorded an average investment of about 4,400 euros, thus totaling for BIOGENERA a collection of more than 2.8 million euros from 644 investors.
BIOGENERA chooses Gitti & Partners as legal advisor
BIOGENERA SpA has chosen the law firm Gitti and Partners as the company’s Legal Advisors for the preparation of the company’s path to listing on the Euronext Paris Stock Exchange.
English 
Italian